Snijders-Keilholz A, De Keizer R J, Goslings B M, Van Dam E W, Jansen J T, Broerse J J
Department of Clinical Oncology, University Hospital Leiden, Netherlands.
Radiother Oncol. 1996 Jan;38(1):69-71. doi: 10.1016/0167-8140(95)01670-8.
Retrobulbar irradiation for Graves' ophthalmopathy is considered as a safe treatment and has recently been recommended as the initial treatment for patients with moderately severe eye problems. However, calculations using risk factors presently known reveal a theoretical risk of radiation-induced cancer of 1.2%. Therefore, the authors suggest that this treatment should be reserved for the elderly patient, for example above the age of 40-50 years.
眼眶后照射治疗格雷夫斯眼病被认为是一种安全的治疗方法,最近已被推荐作为中度严重眼部问题患者的初始治疗方法。然而,根据目前已知的危险因素进行计算显示,辐射诱发癌症的理论风险为1.2%。因此,作者建议这种治疗方法应保留给老年患者,例如年龄在40 - 50岁以上的患者。